Dexamethasone, Elotuzumab, and Pomalidomide in Treating Patients With Refractory Multiple Myeloma

Clinical trial NCT03713294 · COMPLETED

Trial details

NCT number: NCT03713294
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Refractory Plasma Cell Myeloma

Start date: 2019-01-14
Primary completion: 2024-02-20
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.